Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China

Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China

Abstract Aims Proton pump inhibitors (PPI) are widely used for gastroesophageal varices in patients with cirrhosis after endoscopic therapy, although the effect of PPI on these patients remains controversial. This study aimed to evaluate the effect of PPI on gastroesophageal varices in patients with...

Full description

Bibliographic Details
Main Authors:	Xiaoning Chen, Tao Zhou, Ting Zhou, Yueyue Li, Xin Sun, Baoquan Cheng, Ning Zhong, Xuefeng Lu, Yanjing Gao
Format:	Article
Language:	English
Published:	Wiley 2023-03-01
Series:	Portal Hypertension & Cirrhosis
Subjects:	endoscopic therapy gastroesophageal varices liver cirrhosis proton pump inhibitor
Online Access:	https://doi.org/10.1002/poh2.37

Similar Items

PPI efficacy in the reduction of variceal bleeding incidence and mortality, a meta-analysis
by: Sheref A. Elseidy, et al.
Published: (2022-09-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Noninvasive markers for esophageal varices in children with cirrhosis
by: Parisa Rahmani, et al.
Published: (2021-01-01)

Gastric varices: Classification, endoscopic and ultrasonographic management
by: Zeeshan Ahmad Wani, et al.
Published: (2015-01-01)

Recent role of Hassab's operation for cirrhotic patients: Combination with endoscopic procedure for varices
by: Hironori Hayashi, et al.
Published: (2012-04-01)

New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease
by: Jia-li Ma, et al.
Published: (2020-05-01)

Outcome of Post Esophageal Variceal Band Ligation with Sucralfate and Proton Pump Inhibitor vs. Proton Pump Inhibitor Alone in Cirrhotic Patients
by: Binod Karki, et al.
Published: (2019-12-01)

Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy
by: Lingling He, et al.
Published: (2019-06-01)

Proton pumps inhibitors in gastroesophageal reflux disease: what is the best regimen? A based evidence review
by: Rui JF Silva, et al.
Published: (2021-07-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis
by: Qun Zhang, et al.
Published: (2023-01-01)

The Clinical Role of Endoscopic Ultrasound for Management of Bleeding Esophageal Varices in Liver Cirrhosis
by: Kemal Fariz Kalista, et al.
Published: (2022-05-01)

Management of Acute Variceal Bleed by Esophageal Variceal Ligation in an Unconventional Position—An Urban-Center Insight
by: Umesh Jalihal, et al.
Published: (2019-10-01)

Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?
by: Deepanshu Jain, et al.
Published: (2016-03-01)

Growth arrest-specific 6 as a predictor of gastroesophageal varices in patients with liver cirrhosis
by: Khaled A.-A Eid, et al.
Published: (2021-01-01)

Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01)

Audit of Clinical Profile and Outcomes of Acute Variceal Bleed in a Tertiary Care Hospital
by: Anurag Lavekar, et al.
Published: (2019-07-01)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
by: Sirinawasatien A, et al.
Published: (2019-07-01)

Correlation between serum liver fibrosis markers and early gastroesophageal varices among patients with compensated liver cirrhosis: a cross-sectional analysis
by: Ling Mei, et al.
Published: (2022-12-01)

Impact of COVID-19 on endoscopic follow-up of gastroesophageal varices
by: Amr M. Elsayed, et al.
Published: (2022-11-01)

The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors
by: AlShammari M, et al.
Published: (2020-03-01)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01)

The strategy for choosing a new-generation proton pump inhibitor dexlansoprazole in the treatment of gastroesophageal reflux disease
by: N. V. Topchiy, et al.
Published: (2018-04-01)

Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
by: Yichao Shi, et al.
Published: (2023-08-01)

Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis
by: Hiroshi Hisanaga, et al.
Published: (2022-08-01)

Esophageal varices predictive score in liver cirrhosis
by: Dala G Ashraf, et al.
Published: (2018-01-01)

DIAGNOSIS AND TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE – POSSIBILITIES AND LIMITATIONS
by: Gabriela Ciubotariu, et al.
Published: (2016-09-01)

Endoscopic treatment of acute gastric variceal bleeding in patients with cirrhosis using isoamyl-2-cyanoacrylate
by: Tarek A Fouad, et al.
Published: (2019-01-01)

Partial splenic embolization has beneficial effects for the management of gastroesophageal variceal hemorrhage
by: Ping Wang, et al.
Published: (2016-01-01)

Predictors of early rebleeding after endoscopic therapy of first variceal bleeding in liver cirrhosis
by: Maha Salah Abu Alia, et al.
Published: (2021-06-01)

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial
by: Jae Ho Cho, et al.
Published: (2020-08-01)

Development of Fundal Varices in Cirrhotic Patients after Eradication of Esophageal Varices
by: Muhammad Ajmal
Published: (2017-09-01)

Impact of endoscopic ultrasound examination for deep esophageal collateral veins evaluation in liver cirrhosis patients prior to endoscopic treatment: A case series
by: Cosmas Rinaldi A. Lesmana, et al.
Published: (2022-06-01)

How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
by: Yu. V. Evsyutina
Published: (2023-06-01)

Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study
by: Pan Zhang, et al.
Published: (2022-11-01)

Predicting the risk of early bleeding following endoscopic variceal ligation in cirrhotic patients with computed tomography
by: Hwaseong Ryu, et al.
Published: (2023-11-01)

Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding
by: Pavel Drastich, et al.
Published: (2011-04-01)